相似文献
1
Distributing the future: The weak justifications for keeping human genomic databases secret and the challenges and opportunities in reverse engineering them.
Appl Transl Genom. 2014 Dec 1;3(4):124-127. doi: 10.1016/j.atg.2014.09.005.
2
Clients' secret keeping and the working alliance in adult outpatient therapy.
Psychotherapy (Chic). 2009 Jun;46(2):193-202. doi: 10.1037/a0016084.
3
Individual, household and community level factors associated with keeping tuberculosis status secret in Ghana.
BMC Public Health. 2016 Nov 25;16(1):1196. doi: 10.1186/s12889-016-3842-y.
4
Is keeping a secret or being a secretive person linked to psychological symptoms?
J Pers. 2006 Oct;74(5):1349-70. doi: 10.1111/j.1467-6494.2006.00413.x.
5
Two-party secret key distribution via a modified quantum secret sharing protocol.
Opt Express. 2015 Mar 23;23(6):7300-11. doi: 10.1364/OE.23.007300.
6
Justifications and comparisons in the division of household labor: the relevance of gender ideology.
Span J Psychol. 2010 May;13(1):220-31. doi: 10.1017/s1138741600003802.
7
A Maze Matrix-Based Secret Image Sharing Scheme with Cheater Detection.
Sensors (Basel). 2020 Jul 7;20(13):3802. doi: 10.3390/s20133802.
8
Confidentiality principles in psychiatry.
Rev Med Chir Soc Med Nat Iasi. 2015 Jan-Mar;119(1):201-6.
9
Truth-telling and Turner Syndrome: the importance of diagnostic disclosure.
J Pediatr. 2006 Jan;148(1):102-7. doi: 10.1016/j.jpeds.2005.08.022.
10
Hybrid threshold adaptable quantum secret sharing scheme with reverse Huffman-Fibonacci-tree coding.
Sci Rep. 2016 Aug 12;6:31350. doi: 10.1038/srep31350.
引用本文的文献
1
Society and personal genome data.
Hum Mol Genet. 2018 May 1;27(R1):R8-R13. doi: 10.1093/hmg/ddy084.
2
Consistency of and Variant Classifications Among Clinical Diagnostic Laboratories.
JCO Precis Oncol. 2017 Jul;1. doi: 10.1200/PO.16.00020. Epub 2017 Apr 11.
3
Sources of discordance among germ-line variant classifications in ClinVar.
Genet Med. 2017 Oct;19(10):1118-1126. doi: 10.1038/gim.2017.60. Epub 2017 Jun 1.
4
DATA SHARING AND REPRODUCIBLE CLINICAL GENETIC TESTING: SUCCESSES AND CHALLENGES.
Pac Symp Biocomput. 2017;22:166-176. doi: 10.1142/9789813207813_0017.
5
Preventive Genomic Sequencing in the General Population: Do PGS Fly?
Am J Bioeth. 2015;15(7):1-2. doi: 10.1080/15265161.2015.1054160.
本文引用的文献
1
MYRIAD AFTER THE PROPRIETARY DATA DILEMMA.
N C J Law Technol. 2014 Jun;15(4):597-637.
2
Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.
JAMA. 2014 Sep 17;312(11):1091-2. doi: 10.1001/jama.2014.12483.
3
Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.
Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14205-10. doi: 10.1073/pnas.1415979111. Epub 2014 Sep 5.
4
Breast-cancer risk in families with mutations in PALB2.
N Engl J Med. 2014 Aug 7;371(6):497-506. doi: 10.1056/NEJMoa1400382.
5
Development and validation of a new algorithm for the reclassification of genetic variants identified in the BRCA1 and BRCA2 genes.
Breast Cancer Res Treat. 2014 Aug;147(1):119-32. doi: 10.1007/s10549-014-3065-9. Epub 2014 Aug 2.
6
Living laboratory: whole-genome sequencing as a learning healthcare enterprise.
Clin Genet. 2015 Apr;87(4):311-8. doi: 10.1111/cge.12461. Epub 2014 Sep 6.
7
Myriad stands alone.
Nat Biotechnol. 2014 Jul;32(7):620. doi: 10.1038/nbt.2944.
8
Learning to share.
Sci Am. 2014 Jul;311(1):S22.
9
Cancer-gene data sharing boosted.
Nature. 2014 Jun 12;510(7504):198. doi: 10.1038/510198a.
10
Guidelines for investigating causality of sequence variants in human disease.
Nature. 2014 Apr 24;508(7497):469-76. doi: 10.1038/nature13127.
Zotero 插件